Publications, Pharmaceutical

Evaluating the Particle Distribution for Dry Powder Inhalers

Fluidization and disaggregation processes during dry powder inhaler use influence the aerodynamic particle size distribution, permeation, and dissolution of the active pharmaceutical ingredient(s).

This paper describes work to develop an effective test set-up to elucidate these effects by combining laser diffraction particle size distribution measurement (Spraytec) with automated imaging, via Unidose. Unidose is an apparatus developed by Nanopharm, an Aptar company. By capturing the whole impactor sized mass it enables the application of morphologically directed Raman spectroscopy to particles in the size range associated with respiratory drug delivery. Set-ups were tested with different throat models and with different commercially available dry powders inhalers. Particle size distribution data were successfully measured by laser diffraction using the developed test set-ups, and the results were compared with those generated by imaging.

Download Publication
15 Jun 2020

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More

This Might Also Be of Interest

29 May 2025

Overcoming Challenges in Preclinical Studies for Intranasal and Inhalation Programs

Webinars, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Market Insights, Product Solutions

Read More
21 May 2025

Low GWP pMDI Q&A with Aptar’s ZEN30 Futurity™ Valve Solution

Publications, Pharmaceutical, Market Insights, Product Solutions, Sustainability, Drug Delivery Innovations, Brand Differentiation

Read More
19 May 2025

Innovations in Pulmonary Care: DPI and NPLI Lead the Way

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Market Insights, Product Solutions

Read More
23 Apr 2025

Spotlight on Emissions Reductions for A Lower CO2 Footprint in Pharmaceutical Packagi...

Publications, Pharmaceutical, Sustainability, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3 20

Request Access

Close

Requesting access to Evaluating the Particle Distribution for Dry Powder Inhalers.

  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is for validation purposes and should be left unchanged.
Back To Top